These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 7051248)

  • 1. Parenteral trimethoprim-sulfamethoxazole and carbenicillin as empiric therapy for neutropenic patients with cancer.
    Braine HG; Stuart RK; Saral R; Lietman PS
    Rev Infect Dis; 1982; 4(2):586-92. PubMed ID: 7051248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of trimethoprim-sulfamethoxazole singly and in combination with other antibiotics in immunocompromised patients.
    Young LS; Hindler J
    Rev Infect Dis; 1987; 9 Suppl 2():S177-83. PubMed ID: 3554456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trimethoprim-sulfamethoxazole and trimethoprim alone for prophylaxis of infection in granulocytopenic patients.
    Gurwith M; Truog K; Hinthorn D; Liu C
    Rev Infect Dis; 1982; 4(2):593-601. PubMed ID: 6981175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin plus gentamicin and cotrimoxazole for prevention of infections in neutropenic cancer patients (a comparative, placebo-controlled pilot study).
    Malarme M; Meunier-Carpentier F; Klastersky J
    Eur J Cancer Clin Oncol; 1981 Dec; 17(12):1315-22. PubMed ID: 7040086
    [No Abstract]   [Full Text] [Related]  

  • 5. Carbenicillin-trimethoprim/sulfamethoxazole versus carbenicillin-gentamicin as empiric therapy of infection in granulocytopenic patients. A prospective, randomized, double-blind study.
    Stuart RK; Braine HG; Lietman PS; Saral R; Fuller DJ
    Am J Med; 1980 Jun; 68(6):876-85. PubMed ID: 6992570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trimethoprim-sulfamethoxazole in the prevention of infection in neutropenic patients. EORTC International Antimicrobial Therapy Project Group.
    J Infect Dis; 1984 Sep; 150(3):372-9. PubMed ID: 6384377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective gut decontamination with nalidixic acid or trimethoprim-sulfamethoxazole for infection prophylaxis in neutropenic cancer patients: relationship of efficacy to antimicrobial spectrum and timing of administration.
    Bow EJ; Rayner E; Scott BA; Louie TJ
    Antimicrob Agents Chemother; 1987 Apr; 31(4):551-7. PubMed ID: 3300532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trimethoprim-sulfamethoxazole therapy for Pneumocystis carinii pneumonitis in children.
    Hughes WT
    Rev Infect Dis; 1982; 4(2):602-7. PubMed ID: 6981176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of trimethoprim-sulfamethoxazole for treatment of infections in patients with cancer.
    Bodey GP; Grose WE; Keating MJ
    Rev Infect Dis; 1982; 4(2):579-85. PubMed ID: 6981174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of trimethoprim-sulfamethoxazole with ampicillin in acute infectious exacerbations of chronic bronchitis: a double-blind crossover study.
    Chodosh S; Eichel B; Ellis C; Medici TC
    Rev Infect Dis; 1982; 4(2):517-27. PubMed ID: 7051244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Carbenicillin-trimethoprim/sulphamethoxazole or carbenicillin-tobramycin as empirical treatment of infection in granulocytopenic patients. A controlled prospective trial (author's transl)].
    Rafecas FJ; Sanz MA; Balaguer H; Santos M; Besalduch J; Martinez J; Marty ML; Gobernado M
    Sangre (Barc); 1981; 26(3):335-46. PubMed ID: 7027489
    [No Abstract]   [Full Text] [Related]  

  • 12. Protocol for an international prospective trial of initial therapy regimens in neutropenic patients with malignant disease.
    Gaya H; Klastersky J; Schimpff SC; Tattersall MH
    Eur J Cancer (1965); 1975 Aug; 11suppl():1-4. PubMed ID: 767118
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of trimethoprim-sulfamethoxazole in a glucose-6-phosphate dehydrogenase-deficient population.
    Markowitz N; Saravolatz LD
    Rev Infect Dis; 1987; 9 Suppl 2():S218-29. PubMed ID: 3495027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of trimethoprim-sulfamethoxazole in the treatment of chest infections.
    Hughes DT; Russell NJ
    Rev Infect Dis; 1982; 4(2):528-32. PubMed ID: 7051245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of trimethoprim-sulfamethoxazole in the treatment of Pneumocystis carinii pneumonitis in patients with acquired immunodeficiency syndrome.
    Wofsy CB
    Rev Infect Dis; 1987; 9 Suppl 2():S184-94. PubMed ID: 3554457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute cystitis: a prospective study of laboratory tests and duration of therapy.
    Schultz HJ; McCaffrey LA; Keys TF; Nobrega FT
    Mayo Clin Proc; 1984 Jun; 59(6):391-7. PubMed ID: 6427533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coordinated multicenter study of norfloxacin versus trimethoprim-sulfamethoxazole treatment of symptomatic urinary tract infections. The Urinary Tract Infection Study Group.
    J Infect Dis; 1987 Feb; 155(2):170-7. PubMed ID: 2879872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential risks of trimethoprim-sulfamethoxazole prophylaxis in neutropenic patients.
    Riou B; Richard C; Rimailho A; Auzepy P
    J Infect Dis; 1985 May; 151(5):969. PubMed ID: 3872916
    [No Abstract]   [Full Text] [Related]  

  • 19. Trimethoprim-sulfamethoxazole in treatment of severe infections.
    Salter AJ
    Rev Infect Dis; 1982; 4(2):338-50. PubMed ID: 7051234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trimethoprim-sulfamethoxazole and trimethoprim alone in the prophylaxis of childhood urinary tract infection.
    Smellie JM; Grüneberg RN; Normand IC; Bantock HM
    Rev Infect Dis; 1982; 4(2):461-6. PubMed ID: 6981164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.